Table 2.
Gene | Ensembl ID |
Matern et al. (2018) |
Erickson and Nicolson (2015) |
Steiner et al. (2014) |
Lush et al. (2019) |
||||
---|---|---|---|---|---|---|---|---|---|
Log2 FC | Adjusted p value | Log2 FC | Adjusted p value | Log2 FC | Adjusted p value | Log2 FC | Adjusted p value | ||
Chrna9a | ENSDARG00000054680 | 3.655976 | 8.05513E-13* | 2.08078 | 0.040471217* | 4.239971 | 4.78929E-11* | 0.892044 | 7.827853E-116* |
chrna10 | ENSDARG00000011113 | 0.162382 | 1 | −0.15769 | 1 | 0.03275 | 0.849872 | ||
Kcnn1aa | ENSDARG00000091306 | 1.34144 | 0.001182439* | −0.46363 | 1 | 0.789479 | 0.0218807* | ||
Kcnn1b | ENSDARG00000023546 | 0.120795 | 1 | 0.2286 | 1 | 0.11828 | 0.565259 | ||
Kcnn2a | ENSDARG00000014939 | 1.484557 | 0.000490792* | 0.151657 | 1 | 3.958601 | 5.91E-06* | ||
kcnn3 | ENSDARG00000019753 | −0.96006 | 0.413984684 | −0.44232 | 1 | 0.096667 | 0.60571 |
Log2 fold change (FC) and adjusted p values for the genes of interest across the different studies analyzed.
aA gene that shows enrichment of its expression in HC in at least one of the studies.
*Significant adjusted p value.